Rising Biosciences (Rising Biosciences) Short-Term Capital Lease Obligation : $0.00 Mil (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Short-Term Capital Lease Obligation?

Rising Biosciences's Short-Term Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil.

Rising Biosciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Rising Biosciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Short-Term Capital Lease Obligation Chart

Rising Biosciences Annual Data

Trend

Short-Term Capital Lease Obligation

Rising Biosciences Quarterly Data

Short-Term Capital Lease Obligation

Rising Biosciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Rising Biosciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Short-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.